Authoratory™
 
This website is accredited by Health On the Net Foundation. Click to verify.
Bookmark and Share

7Shu-Ming Li

 

Summary for 2004 [at-glance overview of Shu-Ming Li work for the selected year as suggested by data mining algorithms]

This is an Authoratory overview of author Shu-Ming Li. According to available data, in 2004 Shu-Ming Li published at least 7 articles. This work was completed in collaboration with several authors including Heide, Lutz and Gleiter, Christoph H. Many other authors have collaborated with Shu-Ming Li as well. There is no information about the funding or the grants awarded to support this work.

Shu-Ming Li is a key opinion leader on Novobiocin, Coumarins. This author's highest rank is 2 when compared to all other authors using the keyword Novobiocin. Analysis of the article abstracts and the titles suggests that Shu-Ming Li professional interests are focused around "mutational chemoenzymatic approach", "monitoring secondary metabolites" and "combined mutational chemoenzymatic". These might also be referred to as "producer streptomyces", "aminocoumarin antibiotics" or "artemisia annua". Statistical analysis shows that Shu-Ming Li's writing is likely to contains terms "clorobiocin", "streptomyces", "aminocoumarin", "activity", "antibiotics" and "artemisinin".

The majority of Shu-Ming Li articles are affiliated with Pharmazeutische Biologie, Pharmazeutisches Institut, Eberhard-Karls-Universität Tübingen, Auf der Morgenstelle 8, 72076 Tuebingen, Tübingen, Germany and Department of Clinical Pharmacology, Institute of Pharmacology and Toxicology, University Hospital Tübingen, 72076 Tübingen, Germany. Luckily, one email address is on file.

ENFRESRUAccurate information, makes sense to meInaccurate information, needs improvementmake correctionleave commentask question

Images [images we found on the Internet for Shu-Ming Li]

    loading...

    Do you know Shu-Ming Li who matches the profile above? Click the photo and let us know!

Alternative names (0) [other authors with names similar to Shu-Ming Li]

  • none

Year 2004 Charts [Shu-Ming Li frequent coauthors and the most common unique vocabulary terms for the selected year]

  • Shu-Ming Li - Coauthors & Social Network in 2004Shu-Ming Li - Unique Vocabulary, Keywords and Interests in 2004

Historical Performance Charts [graphical overview of Shu-Ming Li publication and funding history for the range of years]

  • Shu-Ming Li - Publications and Funding History in 2004

Emails (1) [email addresses extracted from Shu-Ming Li affiliations]

hidden to prevent spam, click here to reveal

Other [context-specific ads]

Affiliations (5) [condensed summary of the Shu-Ming Li affiliations, the leading number and the color conveys importance]

  • 3Pharmazeutische Biologie, Pharmazeutisches Institut, Eberhard-Karls-Universität Tübingen, Auf der Morgenstelle 8, 72076 Tuebingen, Tübingen, Germany.
    1Department of Clinical Pharmacology, Institute of Pharmacology and Toxicology, University Hospital Tübingen, 72076 Tübingen, Germany.
    1Pharmazeutische Biologie, Pharmazeutisches Institut, D-72076 Tuebingen, Germany.
    1Eberhard-Karls-Universität Tübingen, Pharmazeutische Biologie, Auf der Morgenstelle 8, D-72076 Tuebingen, Germany.
    1Pharmazeutische Biologie, Pharmazeutisches Institut, Universität Tübingen, Tübingen, Germany.

Key Opinion Leader In [Shu-Ming Li is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

  • 2Novobiocin | 3Coumarins | 13DNA Gyrase | 14Streptomyces | 100Anti-Bacterial Agents

Keywords (32) [keywords assigned to Shu-Ming Li articles by PubMed, the leading number and the color conveys importance]

  • 5Novobiocin | 5Anti-Bacterial Agents | 4Streptomyces | 3Coumarins | 3DNA Gyrase | 3Mutation | 2Base Sequence | 2Aminocoumarins | 2Multigene Family | 2Microbial Sensitivity Tests | 2Enzyme Inhibitors | 2Bacillus subtilis | 1Sesquiterpenes | 1DNA, Bacterial | 1Plant Leaves | 1Recombinant Fusion Proteins | 1Artemisinins | 1Biological Availability | 1Cell Extracts | 1Carboxyl and Carbamoyl Transferases | 1Fermentation | 1Chromatography, High Pressure Liquid | 1Area Under Curve | 1Administration, Oral | 1Gene Silencing | 1Actinobacteria | 1Genes, Bacterial | 1DNA, Superhelical | 1Temperature | 1Structure-Activity Relationship | 1Genetic Complementation Test | 1Genetic Engineering

Shu-Ming Li Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Shu-Ming Li might be a good expert witness on these terms]

  • 18clorobiocin | 17streptomyces | 10aminocoumarin | 10activity | 9antibiotics | 9artemisinin | 9novobiocin | 9producer | 8derivatives | 8moiety | 7gyrase | 6iv | 6culture | 5mass | 5antibiotic | 5coumermycin | 5compounds | 5artemisia | 5annua | 5gene | 4novn | 4compound | 4atom | 4analysis | 4isolated | 3tea | 3antibacterial | 3topoisomerase | 3carbamoyltransferase | 3study | 3oral | 3biosynthesis
  • 7producer streptomyces | 6aminocoumarin antibiotics | 5artemisia annua | 5culture extracts | 4clorobiocin producer | 3topoisomerase iv | 3carbamoyltransferase novn | 3combined mutational | 3mass spectrometric | 3chlorine atom | 3streptomyces rishiriensis | 3monitoring secondary | 3annual wormwood | 3pathway monitoring | 3mutational chemoenzymatic | 3secondary metabolites | 3dna gyrase | 3topo iv | 3chemoenzymatic approach | 2coumermycin clorobiocin | 2coli dna | 2study artemisinin | 2methyl group | 2extracts streptomyces | 2prenylated 4-hydroxybenzoic | 2actinobacteria purification | 2reduced activity | 2antibacterial activity | 2herbal tea | 2purification characterization | 2characterization paryr | 2antibiotics formed
  • 3mutational chemoenzymatic approach | 3monitoring secondary metabolites | 3combined mutational chemoenzymatic | 3pathway monitoring secondary | 2topoisomerase iv actinobacteria | 2traditional preparation artemisia | 2purification characterization paryr | 2coumermycin a1 producer | 2actinobacteria purification characterization | 2identification topoisomerase iv | 2spectrometric pathway monitoring | 2culture extracts streptomyces | 2mass spectrometric pathway | 2preparation artemisia annua | 2metabolites systematic analysis | 2streptomyces rishiriensis dsm | 2extracts streptomyces species | 2chemoenzymatic approach utilizing | 2gyrbr coumermycin a1 | 2formed combined mutational | 2nine grams artemisia | 2analysis culture extracts | 2aminocoumarin antibiotics formed | 2study artemisinin oral | 2grams artemisia annua | 2systematic analysis culture | 2oral intake traditional | 2producer streptomyces rishiriensis | 2a1 producer streptomyces | 2intake traditional preparation | 2approach utilizing carbamoyltransferase | 2coli dna gyrase

Reader's Comments (0) [comments posted by readers of Shu-Ming Li profile]

no comments yet

Funding (0) [selected NIH grants to Shu-Ming Li and the award amounts for recent years]

  • award information is not available

Shu-Ming Li Articles (7) [selected PubMed articles for the year 2004 with the links to a full text at PubMed]

  • Mass spectrometric pathway monitoring of secondary metabolites: systematic analysis of culture extracts of Streptomyces species. (2004) >>

    Department of Clinical Pharmacology, Institute of Pharmacology and Toxicology, University Hospital Tübingen, 72076 Tübingen, Germany.

    12Heide, Lutz, 10Gleiter, Christoph H, 4Kammerer, Bernd, 3Kahlich, Rainer, 5Laufer, Stefan, 7Li, Shu-Ming.
  • Production of 8'-halogenated and 8'-unsubstituted novobiocin derivatives in genetically engineered streptomyces coelicolor strains. (2004) >>

    Pharmazeutische Biologie, Pharmazeutisches Institut, Eberhard-Karls-Universität Tübingen Auf der Morgenstelle 8, 72076 Tübingen, Germany.

    12Heide, Lutz, 4Wohlleben, Wolfgang, 2Pelzer, Stefan, 2Chater, Keith F, 2Gust, Bertolt, 7Li, Shu-Ming, 1Eustáquio, Alessandra S.
  • New aminocoumarin antibiotics formed by a combined mutational and chemoenzymatic approach utilizing the carbamoyltransferase NovN. (2004) >>

    Pharmazeutische Biologie, Pharmazeutisches Institut, Eberhard-Karls-Universität Tübingen, Auf der Morgenstelle 8, 72076 Tuebingen, Germany.

    12Heide, Lutz, 32Xu, Hui, 7Li, Shu-Ming.
  • Antimicrobial and DNA gyrase-inhibitory activities of novel clorobiocin derivatives produced by mutasynthesis. (2004) >>

    Pharmazeutische Biologie, Pharmazeutisches Institut, D-72076 Tuebingen, Germany.

    12Heide, Lutz, 3Galm, Ute, 1Page, Malcolm, 1Heller, Stefanie, 3Shapiro, Stuart, 7Li, Shu-Ming.
  • Identification of a topoisomerase IV in actinobacteria: purification and characterization of ParYR and GyrBR from the coumermycin A1 producer Streptomyces rishiriensis DSM 40489. (2004) >>

    Eberhard-Karls-Universität Tübingen, Pharmazeutische Biologie, Auf der Morgenstelle 8, D-72076 Tuebingen, Germany.

    1Schmutz, Elisabeth, 12Heide, Lutz, 2Hennig, Susanne, 7Li, Shu-Ming.
  • New aminocoumarin antibiotics from a cloQ-defective mutant of the clorobiocin producer Streptomyces roseochromogenes DS12.976. (2004) >>

    Pharmazeutische Biologie, Pharmazeutisches Institut, Eberhard-Karls-Universität Tübingen Auf der Morgenstelle 8, 72076 Tübingen, Germany.

    12Heide, Lutz, 3Galm, Ute, 1Freitag, Anja, 7Li, Shu-Ming.
  • Pharmacokinetic study of artemisinin after oral intake of a traditional preparation of Artemisia annua L. (annual wormwood). (2004) >>

    Pharmazeutische Biologie, Pharmazeutisches Institut, Universität Tübingen, Tübingen, Germany.

    12Heide, Lutz, 10Gleiter, Christoph H, 2Taxis, Katja, 1Walz, Gitta, 7Li, Shu-Ming, 1Räth, Karin.

Science Trivia (2) [Interactive math & science trivia questions]